Theravance Biopharma Stock (NASDAQ: TBPH) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 396.582K |
Day Range | - - - |
52 Wk Range | 8.210 - 11.710 |
Market Cap | $479.037M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 60 |
Short Interest | 25.95% |
Days to Cover | 13.97 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Theravance Biopharma (NASDAQ: TBPH) through any online brokerage.
Other companies in Theravance Biopharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Xeris Biopharma Holdings (NASDAQ:XERS).
The latest price target for Theravance Biopharma (NASDAQ: TBPH) was reported by HC Wainwright & Co. on Tuesday, May 14, 2024. The analyst firm set a price target for 20.00 expecting TBPH to rise to within 12 months (a possible 103.05% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Theravance Biopharma (NASDAQ: TBPH) is $9.85 last updated May 15, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Theravance Biopharma.
Theravance Biopharma’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Theravance Biopharma.
Theravance Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.